Reuters: Health
Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.
Acadia Pharma's psychosis drug proven better than placebo in dementia patients
Acadia Pharma's psychosis drug proven better than placebo in dementia patients
Reuters: Health
Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.
Reuters: Health
Acadia Pharmaceuticals Inc said on Wednesday dementia patients taking its drug Nuplazid were nearly three times less prone to a psychotic relapse than those on placebo.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment